Gary Remington's guest appearances

Gary Remington

PsychEd: educational psychiatry podcast

Robin Carhart-Harris

Kwame McKenzie

Andrew Lustig

Roger McIntyre

Mitesh Patel

Juveria Zaheer

Erin Carter

Dana Ross

Jason Joannou

Jared Peck

Ariel Shafro

Mark Sinyor

Sidney Kennedy

Nik Grujich

Ilana Shawn

OwlTail

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode is our fourth and final episode in our mini-series on schizophrenia. In this episode, we take an advanced look at the clinical management of schizophrenia, including a discussion of treatment-resistant schizophrenia and clozapine. Warning: this content in this episode is a little bit more advanced than usual, but also ultra interesting.     Our guest expert is Dr. Gary Remington. He is a researcher, psychiatrist, Chief of the Schizophrenia Division at CAMH and an author of the 2017 Canadian schizophrenia guidelines    The learning objectives for this episode are as follows:    By the end of this episode, the listener will be able to…  Have an approach to treating a first episode psychosis of schizophrenia Understand the important components of maintenance treatment in schizophrenia Understand the concept of treatment-resistant schizophrenia (TRS) Know when to initiate clozapine List some of the psychosocial interventions involved in treating schizophrenia    References:   Remington, G., Addington, D., Honer, W., Ismail, Z., Raedler, T., &amp; Teehan, M. (2017). Guidelines for the pharmacotherapy of schizophrenia in adults. The Canadian Journal of Psychiatry, 62(9), 604-616.   Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., ... &amp; Severe, J. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353(12), 1209-1223. Kapur, S., Remington, G., Jones, C., &amp; Wilson, A. (1996). High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. The American journal of psychiatry, 153(7), 948.    CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association.  For more PsychEd, follow us on Twitter (@psychedpodcast) and Facebook. You can provide feedback by email at psychedpodcast@gmail.com For more information visit our website: psychedpodcast.org.

Welcome to PsychEd, the psychiatry podcast for medical learners, by medical learners. This episode is our fourth and final episode in our mini-series on schizophrenia. In this episode, we take an advanced look at the clinical management of schizophrenia, including a discussion of treatment-resistant schizophrenia and clozapine. Warning: this content in this episode is a little bit more advanced than usual, but also ultra interesting.   Our guest expert is Dr. Gary Remington. He is a researcher, psychiatrist, Chief of the Schizophrenia Division at CAMH and an author of the 2017 Canadian schizophrenia guidelines  The learning objectives for this episode are as follows:  By the end of this episode, the listener will be able to… <ol> <li>Have an approach to treating a first episode psychosis of schizophrenia</li> <li>Understand the important components of maintenance treatment in schizophrenia</li> <li>Understand the concept of treatment-resistant schizophrenia (TRS)</li> <li>Know when to initiate clozapine</li> <li>List some of the psychosocial interventions involved in treating schizophrenia</li> </ol> References: <ul> <li><a href="https://journals.sagepub.com/doi/pdf/10.1177/0706743717720448" rel="nofollow" target="_blank"> Remington, G., Addington, D., Honer, W., Ismail, Z., Raedler, T., &amp; Teehan, M. (2017). Guidelines for the pharmacotherapy of schizophrenia in adults. The Canadian Journal of Psychiatry, 62(9), 604-616.</a></li> </ul> <ul> <li><a href="https://www.nejm.org/doi/full/10.1056/nejmoa051688" rel="nofollow" target="_blank">Lieberman, J. A., Stroup, T. S., McEvoy, J. P., Swartz, M. S., Rosenheck, R. A., Perkins, D. O., ... &amp; Severe, J. (2005). Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. New England Journal of Medicine, 353(12), 1209-1223.</a></li> <li>Kapur, S., Remington, G., Jones, C., &amp; Wilson, A. (1996). High levels of dopamine D2 receptor occupancy with low-dose haloperidol treatment: a PET study. The American journal of psychiatry, 153(7), 948.</li> </ul> CPA Note: The views expressed in this podcast do not necessarily reflect those of the Canadian Psychiatric Association. For more PsychEd, follow us on Twitter (@psychedpodcast) and Facebook. You can provide feedback by email at <a href="mailto:psychedpodcast@gmail.com">psychedpodcast@gmail.com</a> For more information visit our website: <a href="http://psychedpodcast.org/" rel="nofollow" target="_blank">psychedpodcast.org</a>.

PsychEd Episode 12: Treatment of Schizophrenia Part IV Advanced Principles of Schizophrenia Treatment with Dr. Gary Remington